Uniphar

Interim trading statement

  • Jul 28 2026, 07:10 IST/BST
  • Colin Grant
  • Company Report
  • 6 page(s)
  • Sectors : Pharma and healthcare
  • Companies : Uniphar

Ratings and price correct at time of issue.

  • Uniphar

    Closing Price: 447c

  • RATING 27/08/19

  • PREVIOUS RATING N/A

Person's Name

Colin Grant

Analyst

DAVY VIEW

Uniphar’s trading statement for H1 2026 reflects strong operating performance. The outlook is positive on all divisions. The timing of going live on Greenogue II has been extended to reduce execution risk in Q4. Overall, we will be upgrading our FY2026 forecasts once again with no change to our other forecasts.

View full article

Download full report with analyst certification and important disclosures

Jul 28 2026, 07:10 IST/BST

Download